Literature DB >> 22068114

Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.

Yasuhiro Ito1, Takumi Kudo, Minoru Kihara, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya, Akira Miyauchi.   

Abstract

It is well-known that papillary thyroid carcinoma (PTC) has a generally indolent character and shows a favorable prognosis unless it has no high-risk features such as clinical lymph node metastasis, distant metastasis, and significant extrathyroid extension. In this study, we investigated the prognosis of 3,965 patients with PTC without these features. We classified these patients into 3 groups: T-1, tumor ≤ 2 cm (n = 2,591); T-2, tumor 2.1-4 cm (n = 1,123); T-3, tumor > 4 cm (n = 251). Ten-year recurrence rates of T-1, T-2, and T-3 patients were 0.3, 1.3, and 1.9% for the thyroid (in the subset of patients who underwent limited thyroidectomy), 1.9, 4.6, and 8.1% for lymph nodes, and 0.4, 1.6, and 3.4% for distant organs, respectively. A tumor size larger than 2 cm had an independent prognostic impact on all these recurrences also on multivariate analysis. These findings suggest that PTC larger than 2 cm exhibited more aggressive biological characteristics than that measuring 2 cm or less, even though it had no other high-risk features. However, the incidences of distant recurrence and carcinoma death were still low and it remains unclear whether extensive surgery is mandatory for otherwise low-risk PTC patients with large tumor.

Entities:  

Mesh:

Year:  2011        PMID: 22068114     DOI: 10.1507/endocrj.ej11-0288

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  14 in total

1.  Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.

Authors:  Yasuhiro Ito; Takumi Kudo; Kaoru Kobayashi; Akihiro Miya; Kiyoshi Ichihara; Akira Miyauchi
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Ultrasonographic features associated with false-negative and false-positive results of extrathyroidal extensions in papillary thyroid microcarcinoma.

Authors:  Young Chan Lee; Ah Ra Jung; Yu-Mee Sohn; Eui-Jong Kim; Young-Gyu Eun
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-03       Impact factor: 2.503

3.  Retrospective Analysis of 255 Papillary Thyroid Carcinomas ≤2 cm: Clinicohistological Features and Prognostic Factors.

Authors:  Pedro Marques; Valeriano Leite; Maria João Bugalho
Journal:  Eur Thyroid J       Date:  2014-12-06

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

5.  Intrathyroidal tumors presenting with extranodal extension: what are we missing?

Authors:  Jason B Clain; Saral Mehra; Sophie Scherl; Laura L Dos Reis; A Turk; Bruce M Wenig; Eliza H Dewey; Mark L Urken
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

6.  Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience.

Authors:  Ayanthi Wijewardene; Matti Gild; Carolina Nylén; Geoffrey Schembri; Paul Roach; Jeremy Hoang; Ahmad Aniss; Anthony Glover; Mark Sywak; Stan Sidhu; Diana Learoyd; Bruce Robinson; Lyndal Tacon; Roderick Clifton-Bligh
Journal:  Eur Thyroid J       Date:  2021-05-25

7.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

8.  Risk factors associated with intrathyroid extension of thyroid microcarcinomas.

Authors:  Nikola Slijepcevic; Vladan Zivaljevic; Aleksandar Diklic; Milan Jovanovic; Branislav Oluic; Ivan Paunovic
Journal:  Langenbecks Arch Surg       Date:  2018-05-17       Impact factor: 3.445

9.  The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

Authors:  Aldona Kowalska; Agnieszka Walczyk; Iwona Pałyga; Danuta Gąsior-Perczak; Klaudia Gadawska-Juszczyk; Monika Szymonek; Tomasz Trybek; Katarzyna Lizis-Kolus; Dorota Szyska-Skrobot; Estera Mikina; Stefan Hurej; Janusz Słuszniak; Ryszard Mężyk; Stanisław Góźdź
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.

Authors:  Andrej Vogrin; Hana Besic; Nikola Besic; Maja Marolt Music
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.